MiR-126 inhibits colon cancer proliferation and invasion through targeting IRSI, SLC7A5 and TOMI gene

Journal of Central South University (Medical Sciences)

Volumn 38, Issue 8, 2013, Pages 809-817

  Li, Nan ^a   Li, Xiayu ^a   Huang, Shuo ^b   Shen, Shourong ^a   Wang, Xiaoyan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Xiangtan First People's Hospital   (China)

Author keywords

Colon cancer; Lentivirus transfection; Metastasis; MiR 126; Target gene

Indexed keywords

AMINO ACID TRANSPORTER; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, HUMAN; MICRORNA; MIRN126 MICRORNA, HUMAN; PROTEIN; TOM1 PROTEIN, HUMAN;

AGED; CELL PROLIFERATION; COLON TUMOR; FEMALE; GENE TARGETING; GENETIC TRANSFECTION; GENETICS; HUMAN; LENTIVIRINAE; MALE; METABOLISM; MIDDLE AGED; TUMOR CELL LINE; TUMOR INVASION; TUMOR MICROENVIRONMENT;

AGED; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; FEMALE; GENE TARGETING; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; LARGE NEUTRAL AMINO ACID-TRANSPORTER 1; LENTIVIRUS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTEINS; TRANSFECTION; TUMOR MICROENVIRONMENT;

EID: 84884990982     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2013.08.009     Document Type: Article

References (26)

1. Din FV, Theodoratou E, Farrington SM, et al. Effect of aspirin and NSAIDs on risk and survival from colorectal cancer[J]. Gut, 2010, 59(12):1670-1679.
2. Tavazoie SF, Alarcon C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis [J]. Nature, 2008, 451(7175):147-152.
3. Saito Y, Friedman JM, Chihara Y, et al. Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells [J]. Biochem Biophys Res Commun, 2009, 379(3):726-731.
4. Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis[J]. Cancer Cell, 2006, 9(3):189-198. (Pubitemid 43357945)
5. Cho WC, Chow AS, Au JS. Restoration of tumour suppressor hsamiR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation[J]. Eur J Cancer, 2009, 45(12):2197-2206.
6. Feng R, Chen X, Yu Y, et al. miR-126 functions as a tumour suppressor in human gastric cancer[J]. Cancer Lett, 2010, 298(1):50-63.
7. Wang X, Tang S, Le SY, et al. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth[J]. PLoS One, 2008, 3(7):e25S7.
8. Wang X, Wu M, Liu F, et al. Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells[J]. Mol Cell Biochem, 2010, 345(1/2):283-290.
9. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease [J]. Dev Cell, 2006, 11(4):441-450. (Pubitemid 44430905)
10. Croce CM, Calin GA. rruRNAs, cancer and stem cell division[J]. Cell, 2005, 122:6-7. (Pubitemid 40977933)
11. Kim VN, Nam JW. Genomics of microRNA[J]. Trends Genet, 2006, 22(3):165-173.
12. Birney E, Stamatoyannopoulos JA, Dutta A, et al. ENCODE Project Consortium. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project[J]. Nature, 2007, 447(7146):799-816. (Pubitemid 46920138)
13. Calin GA, Croce CM. MicroRNA signatures in human cancers[J]. Nat Rev Cancer, 2006, 6(11):857-866.
14. Deng M, Ye Q, Qin Z, et al. miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma[J]. Tumour Biol, 2013, 34(3):1793-800.
15. Xiaoping L, Zhibin Y, Wenjuan L, et al. CPEB1, a histone-modified hypomethylated gene, is regulated by miR-101 and involved in cell senescence in glioma[J]. Cell Death Dis, 2013, 4:e675.
16. Tavazoie SF, Alarcón C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis[J]. Nature, 2008, 451(7175):147-1S2.
17. Guo C, Sah JF, Beard L, et al. The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers[J]. Genes Chromosomes Cancer, 2008, 47(11):939-946.
18. Crawford M, Brawner E, Batte K, et al. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines[J]. Biochem Biophys Res Commun, 2008, 373(4):607-612.
19. Hansen TF, Srensen FB, Lindebjerg J, et al. The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer[J]. BMC Cancer, 2012, 12:83.
20. Png KJ, Halberg N, Yoshida M, et al. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells[J]. Nature, 2011, 481(7380):190-194.
21. Nowakowska-Zajdel E, Mazurek U, Ziolko E, et al. Analysis of expression profile of gene encoding proteins of signal cascades activated by insulin-like growth factors in colorectal cancer[J]. Int J Immunopathol Pharmacol, 2011, 24(3):781-787.
22. Porter HA, Perry A, Kingsley C, et al. IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors[J]. Cancer left, 2013, 4 [Epub ahead of print].
23. Oglesby IK, Bray IM, Chotirmall SH, et al. miR-126 is downregulated cystic fibrosis airway epithelial cells and regulates TOM1 expression[J], J Immunol, 2010, 184(4):1702-1709.
24. Imai H, Kaira K, Oriuchi N, et al. Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer[J]. Anticancer Res, 2010, 30(12):4819-4828.
25. Ring BZ, Seitz RS, Beck RA, et al. A novel five-antibody immunohistochemical test for subclassification of lung carcinoma[J]. Mod Pathol, 2009, 22(8):1032-1043.
26. Miko E, Margtai Z, Czimmerer Z, et al. miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5[J]. FEBS Lett, 2011, 585(8):1191-1196.